Skyward Specialty director buys 3,200 shares

Skyward Specialty Insurance Group director Peirce Christopher Locke bought 3,200 shares of common stock in an open-market purchase.

Rhea-AI Filing Summary

Skyward Specialty Insurance Group director Peirce Christopher Locke bought 3,200 shares of common stock in an open-market purchase. The transaction took place on March 2, 2026 at a price of $47.30 per share. After this trade, he directly owns 3,200 shares.

Insider Trade Summary

Net Buyer: 3,200 shares

Net Buy 1 txn

Insider Peirce Christopher Locke

Role Director

Bought 3,200 shs ($151K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	3,200	$47.30	$151K

Holdings After Transaction: Common Stock — 3,200 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SKWD director Peirce Christopher Locke report?

Director Peirce Christopher Locke reported buying 3,200 shares of Skyward Specialty Insurance Group common stock. The Form 4 shows this as an open-market purchase at $47.30 per share on March 2, 2026, increasing his directly held position to 3,200 shares.

How many Skyward Specialty (SKWD) shares did the director purchase?

He purchased 3,200 shares of Skyward Specialty Insurance Group common stock. According to the Form 4, this open-market transaction occurred on March 2, 2026 at a price of $47.30 per share, leaving him with 3,200 shares directly owned after the trade.

At what price did the SKWD director buy his shares?

The shares were bought at $47.30 per share. The Form 4 filing states that director Peirce Christopher Locke executed an open-market purchase of 3,200 shares of Skyward Specialty Insurance Group common stock on March 2, 2026 at that reported transaction price.

What is Peirce Christopher Locke’s Skyward Specialty shareholding after this Form 4?

After the reported transaction, he directly owns 3,200 shares. The Form 4 indicates that the 3,200-share open-market purchase on March 2, 2026 brought his total directly held Skyward Specialty Insurance Group common stock position to 3,200 shares.

Was the SKWD director transaction a purchase or a sale?

It was a purchase. The Form 4 records transaction code “P” and describes it as an open-market purchase of 3,200 shares of Skyward Specialty Insurance Group common stock at $47.30 per share on March 2, 2026, increasing his direct holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 10:19 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Peirce Christopher Locke

(Last) (First) (Middle)

800 GESSNER ROAD

SUITE 600

(Street)

HOUSTON TX 77024

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Skyward Specialty Insurance Group, Inc. [ SKWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		P		3,200	A	$47.3	3,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Stacy E. Skelton, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.